What is Teva Pharmaceutical Industries Limited’s (NYSE:TEVA) current market value? Can you beat the fundamentals?

In yesterday’s Wall Street session, Teva Pharmaceutical Industries Limited (NYSE:TEVA) shares traded at $9.62, up 2.89% from the previous session. 13 analysts cover Teva Pharmaceutical Industries Limited (NYSE:TEVA), according to research data. The consensus rating among analysts is ‘Hold’. TEVA stock price is now 8.11% away from the 50-day moving average and 7.24% away from […]

An overview of Teva Pharmaceutical Industries Limited’s (TEVA) institutional holdings

The price of Teva Pharmaceutical Industries Limited (NYSE:TEVA) shares last traded on Wall Street rose 0.31% to $9.70. Based on available information, 13 analysts follow Teva Pharmaceutical Industries Limited (NYSE:TEVA). The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $14.00 and a […]

Do futuristic bulls still own Teva Pharmaceutical Industries Limited [TEVA] stock?

Teva Pharmaceutical Industries Limited (NYSE:TEVA) shares traded 0.53% higher at $9.56 on Wall Street last session. TEVA stock price is now 15.24% away from the 50-day moving average and 7.12% away from the 200-day moving average. The market capitalization of the company currently stands at $10.65B. With the price target enhanced from $7 to $8, […]

A breakdown of the latest mutual funds holding Teva Pharmaceutical Industries Limited (TEVA)

Stocks of Teva Pharmaceutical Industries Limited (NYSE:TEVA) traded higher last session on Wall Street, down -1.33% to $9.63. According to the data, Teva Pharmaceutical Industries Limited (NYSE:TEVA) has 14 analysts covering its stock. The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of […]

An overview of Teva Pharmaceutical Industries Limited’s (TEVA) institutional holdings

In yesterday’s Wall Street session, Teva Pharmaceutical Industries Limited (NYSE:TEVA) shares traded at $8.13, up 1.37% from the previous session. 14 analysts cover Teva Pharmaceutical Industries Limited (NYSE:TEVA), according to research data. The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $14.00 […]